Replication-defective herpes simplex virus vectors for gene transfer in vivo. - Wikidata - wikimedia - TriplyDB

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

http://www.wikidata.org/entity/Q37248260

about

Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis Gene therapy for lower urinary tract dysfunction An HSV vector system for selection of ligand-gated ion channel modulators.A herpes simplex virus vector system for expression of complex cellular cDNA libraries Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.Gene therapy in wound repair and regeneration.Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D Gene therapy for superficial bladder cancer.Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons.Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy.Oncolytic herpes viruses as a potential mechanism for cancer therapy.The role of delta opioid receptors in the anxiolytic actions of benzodiazepines.Development and application of replication-incompetent HSV-1-based vectors.Gene delivery and gene therapy of prostate cancer.Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.Use of viral vectors for the development of vaccines.Gene therapy applications for the treatment of neuropathic pain.High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.Immune responses to herpesviral vectors.Gene therapy as future treatment of erectile dysfunction Viral vectors for gene delivery to the central nervous system.Chapter seven--Cancer treatment with gene therapy and radiation therapy.Herpes simplex viral vectors: late bloomers with big potential.The Scope of Viral Vectors for the Transduction of Haemopoietic Cells.Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form.Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors.Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo.Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion.Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.

P2860

Q24792890-E419C167-99C6-441D-9FA9-7D825F77D9AA Q26824783-BCB8672E-BA63-4422-926D-5A75E1B2A948 Q33293071-C14367DB-55D3-46AB-B694-A94270053E55 Q33576519-3C191437-7069-420E-AD40-A216EB06C830 Q33639601-2ED07E68-BF14-4EB4-A3B9-A31C8CCF1CE9 Q33786002-562603AB-B697-4A36-A6B9-A4A0F0CF02D2 Q33799437-EF0173EC-34B0-4B54-BCC6-9D6595F57F64 Q33895720-FAAF7BA3-C50F-4D13-A32A-7615BDE639C9 Q33995752-B76BEE9A-86C0-4257-B0E3-C30AA5B2374B Q34150713-BEEBC088-109F-4FA5-874E-0785910CD0B2 Q34156741-6EDCCA75-86B6-4480-9A63-236E14C03CC3 Q34233037-4758C909-6D19-4703-95F2-16A8BE5DD6AF Q34734147-85A802C2-09C9-49F3-A08F-C8A2F08305AA Q35037133-B6875136-AEB2-43A1-A335-11984F7D08CA Q35073428-E25478AC-8238-4745-8BB9-F0675ACC652F Q35131218-9B440151-2357-412E-AED2-5477062EAD14 Q35613495-4437D958-A98F-47D3-AF77-FB7E6EA83784 Q35844244-843C2CEA-DA12-4916-ACBD-13A30EB2557F Q36288938-00AB659D-C715-4DE8-BC7F-E1101238D674 Q36349678-D22012C0-AB53-4100-9C1A-06E401BB7D84 Q36457858-04E11BFD-5855-48A4-BEE3-BC40806BBBA2 Q36634794-933164CB-E89E-4181-9DCB-704C80F4441A Q36720700-E6EE92B1-7B67-4BE5-912C-818F8D1B4042 Q36780156-8787071E-6A3D-465B-848F-4AE136B5011A Q36817045-303347B0-E015-4BFC-AAD6-4DFA4D9A055E Q37160338-4D2A7EDD-8B49-43F4-BBD9-2CC97601829A Q37392882-B9644FF2-AE1B-4E64-94C1-F4B3BA261AD8 Q37775988-785A74AF-8669-4D45-AC95-12EDFF3B4A65 Q37946113-EB93FEA4-EA32-449B-ADF2-B229A8DB9FAD Q38047477-0D9AB816-8AB2-4818-BA2C-E79309E32AEB Q38185694-89CB9865-44D9-4FE1-851A-83450BA93E39 Q38896599-A9BABBDC-C861-402A-90A5-FAF35459DFAC Q39756417-40367714-4E7B-4BBC-8C17-493FAE0782EE Q39955631-6873F158-5A65-478F-A4B9-33ACCDA6DB67 Q40161739-DEE5A6AD-31EF-4F71-A113-F35CCB53F39C Q40755343-322C68A9-2BDA-4302-8576-6A94E7F18593 Q40890814-DEF86315-2B91-47F4-92E0-2BBF26AF159D Q40925872-1308900C-F3A9-4AC0-80A5-0077009D433C Q40933757-43C274F1-9936-49CD-BD66-2C6C892D1CE9 Q41931257-2E2CB914-F7B2-410F-87BB-6507BFC67DDE

P2860

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

http://www.wikidata.org/entity/Q37248260

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@en

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@nl

type

label

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@en

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@nl

prefLabel

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@en

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@nl

P1433

Q37248260-60A295DC-E80A-437B-9460-8671EE53D2FA

P1476

Q37248260-F92B6E93-914E-4325-A258-780489EA071D

P2093

Q37248260-0532D87C-6E98-4F79-8C8E-296D15AD0348

Q37248260-35450261-EF9A-4BE4-8BCE-89FAF094B663

Q37248260-7FFDD978-277D-41F7-859A-CD3F2F77058B

Q37248260-8521FED5-087A-402B-B6E6-7224A35E9E2F

Q37248260-AB1E89E2-7F6F-4746-8C83-9CECE83C0478

Q37248260-BC6F4AA8-FFE3-4E0B-AD87-399049820FE6

Q37248260-C6FBF69B-7107-4045-8C92-625573645375

Q37248260-F75716D8-A8FE-4A1E-B3C6-796083E9E00C

P2860

Q37248260-64495DE8-188A-4947-9598-FB063D116593

Q37248260-6DFE9ED3-46A4-4FDD-8D71-FDD7460FE71D

Q37248260-70E3DB54-DFFE-4C5C-97A1-B7C68CA2B645

Q37248260-8B084F26-04FD-45B0-8C8E-7F657AE95EA5

Q37248260-9D8B4D5A-303E-401E-A0EC-F2852D253B7E

Q37248260-A489E2EC-C9CB-4E8C-AE3F-32E62271B102

Q37248260-AD02C729-BE6A-4717-B54D-28D6378CC7B2

Q37248260-B3A14FE8-C4B6-4B21-A2F9-14863AA05FC2

Q37248260-B794F7B8-330D-48BE-8DFF-4FB28C57A85A

Q37248260-CD1C1EF8-E7DF-4C57-A640-DA925AC0F460

P304

Q37248260-BE0C3F9F-C7DF-4631-8C8C-C4AFADC66156

P31

Q37248260-DC41C390-68E3-4B84-AB36-980CF1CB077F

P356

Q37248260-59FDE78E-92AB-421D-80B6-2FA85289A956

P407

Q37248260-D92A5D90-BA79-443B-860C-5934E12B7676

P433

Q37248260-34C0B1AA-DFEC-45F4-B434-5FE5665A69C3

P478

Q37248260-DA54EA56-994D-4595-A1DA-BC4CFA990A38

P577

Q37248260-324857F6-C8B2-4638-8ED7-C41E3FC4FF0F

P5875

Q37248260-54510CF8-86A7-4062-9BC5-CE041BD0063B

P698

Q37248260-F19039B2-EFCA-4565-A951-5B811DF6E854

P921

Q37248260-3345F5D7-19A1-41D7-B386-842D6A11F7D2

P932

Q37248260-8730E3E7-9F87-4E96-89B8-CFFFFB671092

P356

PNAS.93.21.11319

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

@en

P2093

Fink DJ

http://www.w3.org/2001/XMLSchema#string

Glorioso JC

http://www.w3.org/2001/XMLSchema#string

Goins WF

http://www.w3.org/2001/XMLSchema#string

Krisky D

http://www.w3.org/2001/XMLSchema#string

Marconi P

http://www.w3.org/2001/XMLSchema#string

Oligino T

http://www.w3.org/2001/XMLSchema#string

Poliani PL

http://www.w3.org/2001/XMLSchema#string

Ramakrishnan R

http://www.w3.org/2001/XMLSchema#string

P2860

Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.

Long-term promoter activity during herpes simplex virus latency

Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient

Control of mRNA stability by the virion host shutoff function of herpes simplex virus

Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function.

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.

Gene transfer to neurons using herpes simplex virus-based vectors.

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

P304

11319-11320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.21.11319

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14331028

http://www.w3.org/2001/XMLSchema#string

P698

8876133

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

38055

http://www.w3.org/2001/XMLSchema#string